[go: up one dir, main page]

Kairemo et al., 1999 - Google Patents

Ets-1 mRNA as target for antisense radio-oligonucleotide therapy in melanoma cells

Kairemo et al., 1999

Document ID
16220474683583062802
Author
Kairemo K
Thorstensen K
Mack M
Tenhunen M
Jekunen A
Publication year
Publication venue
Gene Ther Mol Biol

External Links

Continue reading at scholar.google.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy

Similar Documents

Publication Publication Date Title
Shi et al. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells.
US5734039A (en) Antisense oligonucleotides targeting cooperating oncogenes
Lee et al. O 6-Alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine
EP0458829B1 (en) Methods and compositions for treatment of cancer using oligonucleotides
US5618709A (en) Antisense oligonucleotides specific for STK-1 and method for inhibiting expression of the STK-1 protein
Kargiotis et al. Effects of irradiation on tumor cell survival, invasion and angiogenesis
Sgouros et al. MIRD continuing education: bystander and low–dose-rate effects: are these relevant to radionuclide therapy?
CN101951926A (en) Radiation Sensitivity Enhanced Compositions Comprising MicroRNA-21 Inhibitors
Varani et al. In vitro and in vivo adherence of tumor cell variants correlated with tumor formation
Kaplan et al. The nucleus is the target for radiation-induced chromosomal instability
AU5005093A (en) Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer
Kairemo et al. Ets-1 mRNA as target for antisense radio-oligonucleotide therapy in melanoma cells
US20040067197A1 (en) Radiolabeled DNA carrier, method of preparation and therapeutic uses thereof
Uckun et al. Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia.
US5821354A (en) Radiolabeled DNA oligonucleotide and method of preparation
Morgenroth et al. Breaking the invulnerability of cancer stem cells: two-step strategy to kill the stem-like cell subpopulation of multiple myeloma
Hill et al. Lethal and kinetic effects of DDMP (2, 4-diamino-5-(3′, 4′-dichlorophenyl)-6-methylpyrimidine)
Zvereva et al. Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics
Glück et al. Radiosensitivity of human clonogenic myeloma cells and normal bone marrow precursors: effect of different dose rates and fractionation
US6339071B1 (en) Antisense oligonucleotide modulating cyclin E gene expression and therapeutic uses thereof
Abu-Gheida et al. Radiobiology of stereotactic radiosurgery
Masunaga et al. Inhibition of repair of radiation-induced damage by mild temperature hyperthermia, referring to the effect on quiescent cell populations
Lawrence et al. Lack of dependence of 5-fluorodeoxyuridine-mediated radiosensitization on cytotoxicity
KR101617749B1 (en) Composition comprising HAS2 inhibitor for enhancing radiation sensitivity
Harwood et al. Utilization of 3H-5-uridine for RNA synthesis in ehrlich ascites tumour cells